Clinical Trial Update: COmbination of Radiotherapy With Anti-PD-1 Antibody for unREseCtable Biliary Tract Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the combination of radiotherapy with anti-PD-1 immunotherapy for unresectable biliary tract cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer

Drugs mentioned

• Anti-PD-1 antibody

Snippet

Sponsor: Sun Yat-sen University | Conditions: Biliary Tract Cancer, Radiotherapy | Phase 2 | Status: UNKNOWN